Skip to main content
. 2020 Mar 23;23(18):3379–3386. doi: 10.1017/S1368980019004166

Table 1.

Diagnosis criteria of metabolic syndrome used in current study

MetS component Modified ATP III criteria IDF criteria Harmonised definition
Number of risk factors Three or more of… Obesity and 2 of… Three or more of…
Obesity WC ≥90 cm for Asian-origin male
WC ≥80 cm for Asian-origin female
WC ≥90 cm for Chinese male
WC ≥80 cm for Chinese female
WC ≥85 cm for Chinese male
WC ≥80 cm for Chinese female
Dyslipidaemia
 TAG ≥1·7 mmol/l or drug treatment for elevated TAG ≥1·7 mmol/l or specific treatment for this lipid abnormality ≥1·7 mmol/l or drug treatment for elevated TAG
 HDL <1·03 mmol/l in men or <1·29 mmol/l in women or drug treatment for reduced HDL-cholesterol <1·03 mmol/l in men or <1·29 mmol/l in women or specific treatment for this lipid abnormality <1·03 mmol/l in men or <1·29 mmol/l in women or drug treatment for reduced HDL-cholesterol
Blood pressure SBP ≥130 mmHg or/and DBP ≥85 mmHg or drug treatment for hypertension SBP ≥130 mmHg or/and DBP ≥85 mmHg or treatment of previously diagnosed hypertension SBP ≥130 mmHg or/and DBP ≥85 mmHg
or drug treatment for hypertension
Hyperglycaemia FBG ≥5·6 mmol/l or drug treatment for elevated glucose FBG ≥5·6 mmol/l or previously diagnosed T2DM ≥5·6 mmol/l or drug treatment for elevated glucose

SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose.